ImmunoPrecise Antibodies | SC 13G: Statement of acquisition of beneficial ownership by individuals-INGALLS & SNYDER LLC(5.01%)
ImmunoPrecise Antibodies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Charmquark TWEE(6.28%),Charmquark EEN(6.28%)
ImmunoPrecise Antibodies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Charmquark TWEE(6.40%),Charmquark EEN(6.40%)
ImmunoPrecise Antibodies | SC 13D: Statement of acquisition of beneficial ownership by individuals-Ingalls & Snyder, LLC(4.22%)
ImmunoPrecise Antibodies | D: Filing D
ImmunoPrecise Antibodies | D: Filing D
ImmunoPrecise Antibodies | D: Filing D
No Data